AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Translesional PRESSURE Measurements to Assess Clinical Relevance of a Mesenteric Artery Stenosis (PRESSURE-study)

Recruitingn/aAges 18 Years - anyAllErasmus Medical Center
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Chronic mesenteric ischemia (CMI) is an incapacitating disease with a vast impact on quality of life due to severe abdominal pain after a meal, resulting in fear of eating and subsequent weight loss. CMI is most frequently caused by an atherosclerotic mesenteric artery stenosis, which is a frequent finding in the general population (6-29%). CMI is less prevalent due to an extensive collateral circulation protecting the gut against ischemia. Hence, imaging alone cannot be relied upon, making the diagnosis of CMI challenging. Treatment decisions for atherosclerotic CMI are currently based on history, stenosis severity on imaging, and signs of mesenteric ischemia during a functional test. Yet, sufficiency of the collateral circulation cannot be assessed, resulting in substantial failure to recover from symptoms after stentplacement (27-31% in single vessel disease), unnecessary complicatio

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * All patients with chronic mesenteric ischemia (CMI) and scheduled for endovascular procedure of the mesenteric arteries * Age โ‰ฅ18 years of age * Patients who gave informed consent Exclusion Criteria: * Patients presenting with acute mesenteric ischemia * Common origin of the SMA and CA (normal variant) * Patients unable to give informed consent * Pregnancy * Other criteria the physician considers not compatible with this study
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

3 sites
Medisch Spectrum Twente
Enschede, Netherlands
Erasmus University Medical Centre Rotterdam
Rotterdam, Netherlands
Franciscus
Rotterdam, Netherlands
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy